EUVIMEDEUVIMED entdecken
Multizentrische Studie

Sirolimus-coated balloon in acute and chronic coronary syndromes: the PEACE study, a subanalysis of the EASTBOURNE registry

Alessandra Laricchia, Irene Bossi, Roberto A Latini, Chuey Y Lee, Ignacio S Pérez, Fabrizio Tomai, Amin A Nuruddin, Dario Buccheri, Giuseppe Seresini, Raymundo Ocaranza, Gunasekaran Sengottvelu, Nicola Pesenti und 3 weitere

Revista Española de Cardiología (English Edition) · 2024

DOI: 10.1016/j.rec.2023.11.010 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Revista Española de Cardiología (English Edition), 2024. Verfasst von Alessandra Laricchia und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Ospedale San Carlo Borromeo, Milan, Italy; Cardiology Department, Ospedale Fatebenefratelli, Milan, Italy. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Sirolimus, Registries, Coronary Angiography. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: The PEACE study (Performance of a sirolimus-eluting balloon strategy in acute and chronic coronary syndromes) investigated for the first time whether a sirolimus-coated balloon (SCB) (Magic Touch, Concept Medical, India) is associated with different outcomes depending on whether it is used in acute coronary syndromes (ACS) or chronic coronary syndromes (CCS). METHODS: This was a post-hoc analysis from the all-comers EASTBOURNE Registry (NCT03085823). Out of 2083 patients enrolled, an SCB was used to treat 968 (46.5%) ACS and 1115 (53.5%) CCS patients. The primary endpoint was target lesion revascularization at 12 months, while secondary endpoints were angiographic success and major adverse cardiovascular events. RESULTS: Baseline demographics, mean reference vessel diameter and mean lesion length were comparable between ACS and CCS. Predilatation was more commonly performed in ACS (P=.007). SCB was inflated at a standard pressure in both groups with a slight trend toward longer inflation time in ACS. Angiographic success was high in both groups (ACS 97.4% vs CCS 97.7%, P=.820) with limited bailout stenting. Similarly, at 12 months the cumulative incidence of target lesion revascularization (ACS 6.6% vs CCS 5.2%, P=.258) was comparable between ACS and CCS. Conversely, a higher rate of major adverse cardiovascular events in acute presenters was mainly driven by myocardial infarction recurrencies (ACS 10.4% vs CCS 8.3%, P=.009). In-stent restenosis showed a higher proportion of target lesion revascularization and major adverse cardiovascular events than de novo lesions, independently of the type of presentation at the index procedure. CONCLUSIONS: This SCB shows good performance in terms of acute and 1-year outcomes independently of the clinical presentation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeSirolimusRegistriesCoronary AngiographyAngioplasty, Balloon, CoronaryHumansMaleFemaleMiddle AgedAgedTreatment OutcomeChronic DiseaseDrug-Eluting StentsFollow-Up StudiesCoated Materials, Biocompatible

Stichwörter der Autor:innen

Acute coronary syndromeAngioplastia coronariaBalón recubierto de fármacoBalón recubierto de sirolimusChronic coronary syndromeDrug-coated balloonPercutaneous coronary interventionSirolimus-coated balloonSíndrome coronario agudoSíndrome coronario crónico

Substanzen

SirolimusCoated Materials, Biocompatible

Autor:innen und Institutionen

  • Cardiology Department, Ospedale San Carlo Borromeo, Milan, Italy; Cardiology Department, Ospedale Fatebenefratelli, Milan, Italy.
  • Cardiology Department, Ospedale Niguarda, Milan, Italy.
  • Cardiology Department, Ospedale Fatebenefratelli, Milan, Italy.
  • Cardiology Department, Sultanah Aminah Hospital Johor Bahru, Johor, Malaysia.
  • Cardiology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
  • Cardiology Department, European Hospital, Roma, Italy.

Zitieren

APA

Laricchia, A., Bossi, I., Latini, R. A., Lee, C. Y., Pérez, I. S., Tomai, F., Nuruddin, A. A., Buccheri, D., Seresini, G., Ocaranza, R., Sengottvelu, G., Pesenti, N., Mangieri, A., Cortese, B., & EASTBOURNE investigators (2024). Sirolimus-coated balloon in acute and chronic coronary syndromes: the PEACE study, a subanalysis of the EASTBOURNE registry. Revista Española de Cardiología (English Edition). https://doi.org/10.1016/j.rec.2023.11.010

Vancouver

Laricchia A, Bossi I, Latini RA, Lee CY, Pérez IS, Tomai F, et al. Sirolimus-coated balloon in acute and chronic coronary syndromes: the PEACE study, a subanalysis of the EASTBOURNE registry. Revista Española de Cardiología (English Edition). 2024. doi:10.1016/j.rec.2023.11.010

BibTeX
@article{Laricchia2024,
  author = {Laricchia, Alessandra and Bossi, Irene and Latini, Roberto A and Lee, Chuey Y and Pérez, Ignacio S and Tomai, Fabrizio and Nuruddin, Amin A and Buccheri, Dario and Seresini, Giuseppe and Ocaranza, Raymundo and Sengottvelu, Gunasekaran and Pesenti, Nicola and Mangieri, Antonio and Cortese, Bernardo and EASTBOURNE investigators, EASTBOURNE investigators},
  title = {Sirolimus-coated balloon in acute and chronic coronary syndromes: the PEACE study, a subanalysis of the EASTBOURNE registry},
  journal = {Revista Española de Cardiología (English Edition)},
  year = {2024},
  doi = {10.1016/j.rec.2023.11.010}
}
Kostenlos starten →